ResearcherNational Physical LaboratoryActive in the last 2 years
Claire A. Price
Matched on ORCID iD 0000-0003-3060-9821; OpenAlex author ID A5056940844. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 1 paper · 2026: 3 papers
Papers 7
- Quantifying Weight Loss Prior to Pancreatic Cancer Diagnosis: A Systematic Review and Meta-Analysis. Co-author DOI 10.1002/cam4.71997↗
- Comparing Weight Loss Prior to Pancreatic Cancer Diagnosis in Cases and Controls: A Systematic Review and Meta-Analysis. Co-author DOI 10.3233/shti260172↗
- Enriching New-onset Diabetes for Pancreatic Cancer (ENDPAC): external validation using English sentinel network. Co-author DOI 10.3399/bjgp.2024.0253↗
- Sociodemographic Profile of People with Diagnosed Pancreatic Cancer in the UK: Retrospective Sentinel Network Cohort Study. Co-author DOI 10.3233/shti250563↗
- External UK validation of the ENDPAC model to predict pancreatic cancer risk: A registered report protocol Co-author DOI 10.1101/2024.05.21.24307690↗
- Determining the feasibility of calculating pancreatic cancer risk scores for people with new-onset diabetes in primary care (DEFEND PRIME): study protocol. First author DOI 10.1136/bmjopen-2023-079863↗
- BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database. First author DOI 10.1371/journal.pone.0275369↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Agnieszka Lemańska · 7 shared papers, 2022–2026 · strength 1.89
- Paper Quantifying Weight Loss Prior to Pancreatic Cancer Diagnosis: A Systematic Review and Meta-Analysis. DOI 10.1002/cam4.71997↗
- Paper Comparing Weight Loss Prior to Pancreatic Cancer Diagnosis in Cases and Controls: A Systematic Review and Meta-Analysis. DOI 10.3233/shti260172↗
- Paper Enriching New-onset Diabetes for Pancreatic Cancer (ENDPAC): external validation using English sentinel network. DOI 10.3399/bjgp.2024.0253↗
- Simon de Lusignan · 6 shared papers, 2022–2026 · strength 1.53
- Paper Comparing Weight Loss Prior to Pancreatic Cancer Diagnosis in Cases and Controls: A Systematic Review and Meta-Analysis. DOI 10.3233/shti260172↗
- Paper Enriching New-onset Diabetes for Pancreatic Cancer (ENDPAC): external validation using English sentinel network. DOI 10.3399/bjgp.2024.0253↗
- Paper Sociodemographic Profile of People with Diagnosed Pancreatic Cancer in the UK: Retrospective Sentinel Network Cohort St… DOI 10.3233/shti250563↗
- Hugh Claridge · 3 shared papers, 2024–2026 · strength 0.73
- Paper Enriching New-onset Diabetes for Pancreatic Cancer (ENDPAC): external validation using English sentinel network. DOI 10.3399/bjgp.2024.0253↗
- Paper External UK validation of the ENDPAC model to predict pancreatic cancer risk: A registered report protocol DOI 10.1101/2024.05.21.24307690↗
- Paper Determining the feasibility of calculating pancreatic cancer risk scores for people with new-onset diabetes in primary … DOI 10.1136/bmjopen-2023-079863↗
- Natalia I. Khalaf · 3 shared papers, 2024–2026 · strength 0.73
- Paper Enriching New-onset Diabetes for Pancreatic Cancer (ENDPAC): external validation using English sentinel network. DOI 10.3399/bjgp.2024.0253↗
- Paper External UK validation of the ENDPAC model to predict pancreatic cancer risk: A registered report protocol DOI 10.1101/2024.05.21.24307690↗
- Paper Determining the feasibility of calculating pancreatic cancer risk scores for people with new-onset diabetes in primary … DOI 10.1136/bmjopen-2023-079863↗
- Martin Whyte · 1 shared paper, 2022 · strength 0.14
- Nathan Jeffreys · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.